PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins
Sign Up to like & getrecommendations! Published in 2017 at "Movement Disorders"
DOI: 10.1002/mds.27029
Abstract: Background and Objectives: To study selective regional binding for tau pathology in vivo, using PET with [11C]PBB3 in PSP patients, and other conditions not typically associated with tauopathy. read more here.
Keywords: disorders evidence; pbb3 imaging; imaging parkinsonian; binding tau ... See more keywords
MicroRNAs to differentiate Parkinsonian disorders: Advances in biomarkers and therapeutics
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the Neurological Sciences"
DOI: 10.1016/j.jns.2018.08.032
Abstract: Parkinsonian disorders are a set of progressive neurodegenerative movement disorders characterized by rigidity, tremor, bradykinesia, postural instability and their distinction has significant implications in terms of management and prognosis. Parkinson's disease (PD) is the most… read more here.
Keywords: differentiate parkinsonian; advances biomarkers; disorders advances; parkinsonian disorders ... See more keywords
Therapeutic Application of rTMS in Atypical Parkinsonian Disorders
Sign Up to like & getrecommendations! Published in 2021 at "Behavioural Neurology"
DOI: 10.1155/2021/3419907
Abstract: The terms atypical parkinsonian disorders (APDs) and Parkinson plus syndromes are mainly used to describe the four major entities of sporadic neuronal multisystem degeneration: progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA),… read more here.
Keywords: therapeutic application; rtms atypical; atypical parkinsonian; application rtms ... See more keywords
Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Aging Neuroscience"
DOI: 10.3389/fnagi.2022.909552
Abstract: Objectives We employed quantitative susceptibility mapping (QSM) to assess iron deposition in parkinsonian disorders and explored whether combining QSM values and neurofilament light (NfL) chain levels can improve the accuracy of distinguishing Parkinson’s disease (PD)… read more here.
Keywords: parkinsonian disorders; susceptibility mapping; susceptibility; nfl levels ... See more keywords
A New Statistical Framework for Corpus Callosum Sub-Region Characterization Based on LBP Texture in Patients With Parkinsonian Disorders: A Pilot Study
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Neuroscience"
DOI: 10.3389/fnins.2020.00477
Abstract: Purpose The study is conducted to identify the best corpus callosum (CC) sub-region that corresponds to highest callosal tissue alteration occurred due to Parkinsonism. In this regard the efficacy of local binary pattern (LBP) based… read more here.
Keywords: callosum sub; corpus callosum; sub region; texture ... See more keywords
Molecular Imaging in Parkinsonian Disorders—What’s New and Hot?
Sign Up to like & getrecommendations! Published in 2022 at "Brain Sciences"
DOI: 10.3390/brainsci12091146
Abstract: Highlights Imaging of the dopamine transporter (DAT) (in particular using 11C- or 18F-PE2I) most reliably and precisely measures neurodegeneration of the dopaminergic system in parkinsonian disorders and its progression in longitudinal studies. Combining DAT imaging… read more here.
Keywords: parkinsonian disorders; diagnosis; molecular imaging; disease ... See more keywords
Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders
Sign Up to like & getrecommendations! Published in 2020 at "Turkish Journal of Medical Sciences"
DOI: 10.3906/sag-2008-253
Abstract: The dopamine transporter (DAT) imaging provides an objective tool for the assessment of dopaminergic function of presynaptic terminals which is valuable for the differential diagnosis of parkinsonian disorders related to a striatal dopaminergic deficiency from… read more here.
Keywords: spect; spect imaging; parkinson disease; dopamine transporter ... See more keywords